Equid alphaherpesvirus 1

Last updated
Equid alphaherpesvirus 1
Virus classification Red Pencil Icon.png
(unranked): Virus
Realm: Duplodnaviria
Kingdom: Heunggongvirae
Phylum: Peploviricota
Class: Herviviricetes
Order: Herpesvirales
Family: Herpesviridae
Genus: Varicellovirus
Species:
Equid alphaherpesvirus 1
Synonyms
  • Equid herpesvirus 1 [1]
  • Equine herpesvirus 1

Equid alphaherpesvirus 1, formerly Equine herpesvirus 1 (EHV-1), is a virus of the family Herpesviridae that causes abortion, respiratory disease and occasionally neonatal mortality in horses. Initial spread of EHV-1 by a newly introduced horse through direct and indirect contact can lead to abortion and perinatal infection in up to 70 percent of a previously unexposed herd. [2] Abortion usually occurs in the last four months of gestation, two to four weeks after infection of the mare. [3] Perinatal (around the time of birth) infection can lead to pneumonia and death. Encephalitis can occur in affected animals, leading to ataxia, paralysis, and death. There is a vaccine available (ATCvet code QI05AA11 ( WHO )), however its efficacy is questionable.[ citation needed ] The virus varies in severity from sub-clinical to very severe. [4] Most horses have been infected with EHV-1, but the virus can become latent and persist without ever causing signs of infection. [5] In 2006, an outbreak of EHV-1 among stables in Florida resulted in the institution of quarantine measures. [6] The outbreak was determined to have originated in horses imported from Europe via New York, before being shipped to Florida. [7]

Contents

Strains

Two main strains of EHV-1 have been isolated. D752 strains are correlated to outbreaks associated with neurological disease, whereas outbreaks with non-neurological disease are more closely associated with strains of N752. However, not all horses infected with D752 strains develop neurological disease; conversely, some horses infected with N752 strains will develop neurological disease. [8] A mutation results in both these two different main strains, D752 is the presence of aspartic acid and the N752 is the presence of asparagine. 80–90% of neurological disease is caused by the D752, and 10–20% for N752. [4] The disease caused by neurological strains has been named Equine Herpesvirus Myeloencephalopathy or EHM. There is currently no licensed vaccine against EHM and no treatment other than palliative care. [9] The disease rose to worldwide public prominence in early 2011, due to an outbreak centered on the National Cutting Horse Association (NCHA) Western National Championships held in Ogden, Utah from April 29 to May 8, 2011. The outbreak lasted approximately two months, generating 90 confirmed cases of the disease, spread over 10 American states, and resulting in the deaths of 13 horses before it was declared contained by the US Department of Agriculture. [10]

Latency

The EHV-1 virus can latently infect horses and can reactivate if appropriate conditions appear. These conditions include high levels of stress, immunosuppression, transportation, [11] sale barns, competitions, [12] geological and management practices. Current studies that have been done are showing that a majority of horses are actually latently infected with EHV-1. The consequence of latency is that in fact, it can cause an outbreak of EHV-1 in a closed group of horses, without any external source. Latent infected horses do not shed EHV-1 through nasal secretions and therefore are not infectious and are called clinically normal. [12]

Signs, symptoms and transmission

The signs that occur with EHV-1 and the EHM strain may include the following: decreased coordination, urine dribbling, fever, hind limb weakness, leaning against things to maintain balance, and lethargy. [5] .Some horses may be asymptomatic upon infection increasing the difficulty in controlling the spread of the virus. Due to the nature of the virus being highly contagious, a common reservoir of the virus can include contaminated bedding. Fetuses that may have been aborted and their excrements are the major reservoir for EHV-1 and should be immediately disposed of upon abortion. Although infected horses build some type of immunity through repeated exposure of the virus, there has been no evidence of adaptive immunity to provide protection against the most severe symptoms of EHV-1 including EHM. p. [4]

Risk factors

Scientists have identified multiple risk factors that increase a horse's susceptibility to EHV-1. The variation in risk factors is due to the numerous EHV-1 strains that may cause infection. Common risk factors seen in all EHV-1 infections include the age, sex, and gender of the horse. Additional risk factors that vary depending on the type of EHV-1 strain present include the following: living quarters (confined or pastured), prevalence of other horses, unsterilized equipment shared between horses, transportation (hauling) and what time of year infection is present (winter or summer). Stabled horses are prone to EHV-1 due to the high stress environments seen in confined living quarters. As seen in other viral infections, older horses are more susceptible to the disease therefore treatment is advised for those that fit this category to prevent EHV-1 infection. [12]

Diagnosis, treatment and prevention

Treatment

The current diagnosis used for detecting EHV-1 involves PCR which amplifies a segment of DNA from the horse using specific primers that target EHV-1's genetic makeup. To determine whether the reaction amplified a genetic region of interest (ie. primers specific to EHV-1) the PCR result is viewed using UV fluorescence where a determination can be made based on the size of the genetic region amplified; the size of the amplified DNA can be measured by the number of base pairs and compared to the number of base pairs that the EHV-1 primers amplified. A match in base pairs seen in the reaction amplified to the primers used indicates a horse has been infected with EHV-1. [8] Samples acquired from susceptible horses exposed to EHV-1 can be determined from a blood test or nasal swab. Although the PCR test has been a gold standard for many years in determining whether one harbors a certain infection, it is time consuming and there is a chance EHV-1 may not be detected in the DNA sample if the horse is in fact infected. This is common among horses that are latently infected where the virus is not actively replicating and therefore producing multiple copies of its genetic sequence. If a horse is in fact infected with EHV-1, treatment options are limited with the use of anti-inflammatory drugs administered either orally or intravenously. Even then, prognosis of the horse results in treatment that may alleviate EHV-1 symptoms presented (if symptomatic), but cannot be used to eliminate infection as no treatment to date has been found to do so.

Prevention

Vaccines exist to control the virus but not to prevent it. The inactivated vaccine contain a low antigen load and are made to help protect against the respiratory symptoms, the performance of the inactivated vaccines is variable and does not work for all. [4] The modified live vaccine is made to vaccinate healthy horses 3 months or older, to help prevent the respiratory symptoms caused by EHV-1. Vaccinations should be given in 6-month intervals, and different horses will need to be vaccinated at different times. [4] Pregnant mares should be vaccinated during the fifth, seventh and ninth months of gestation, with the inactivated EHV-1 vaccine. Foals should be vaccinated in a series of 3 doses starting at 3 months in 4–6 week intervals. [4] Even though a horse has been vaccinated, infection and clinical disease still continues to occur. New vaccines to help prevent the spread of the virus are being studied. [5]

To prevent the spread of EHV-1, there are a few steps that should be taken. Most important is to stop horse movement and transportation; not allowing horses that have been exposed to EHV-1 to be in contact with unexposed horses; and to isolate animals that are showing symptoms of the virus. [5] Ideally, horses that are showing symptoms should be completely quarantined. The recommended quarantined period is at least 21 days. [11] Another facet of EHV-1 control is to be aware of the potential for spreading the virus via equipment, and transmission, via human contact, between horses. Since people can and do transfer this virus via their hands and clothing, people need to take sanitary precautions when handling a sick horse. Disinfecting footwear and wearing gloves can help minimize the risk of spreading. [5] Routinely cleaning and disinfecting the barns and buildings where horses have been is important for preventing transmission. [11] In the case of an outbreak, one should also take precautions to minimize stress on the horses. As stated previously, stress will trigger a latent virus to reactivate, and it can allow an uninfected horse to be more easily infected. [11]

Related Research Articles

<span class="mw-page-title-main">Mumps</span> Human disease caused by paramyxovirus

Mumps is a viral disease caused by the mumps virus. Initial symptoms are non-specific and include fever, headache, malaise, muscle pain, and loss of appetite. These symptoms are usually followed by painful swelling of the parotid glands, called parotitis, which is the most common symptom of infection. Symptoms typically occur 16 to 18 days after exposure to the virus and resolve within two weeks. About one third of infections are asymptomatic.

<span class="mw-page-title-main">Virulent Newcastle disease</span> Contagious viral avian disease

Virulent Newcastle disease (VND), formerly exotic Newcastle disease, is a contagious viral avian disease affecting many domestic and wild bird species; it is transmissible to humans. Though it can infect humans, most cases are non-symptomatic; rarely it can cause a mild fever and influenza-like symptoms and/or conjunctivitis in humans. Its effects are most notable in domestic poultry due to their high susceptibility and the potential for severe impacts of an epizootic on the poultry industries. It is endemic to many countries. No treatment for VND is known, but the use of prophylactic vaccines and sanitary measures reduces the likelihood of outbreaks.

Marek's disease is a highly contagious viral neoplastic disease in chickens. It is named after József Marek, a Hungarian veterinarian who described it in 1907. Marek's disease is caused by an alphaherpesvirus known as "Marek's disease virus" (MDV) or Gallid alphaherpesvirus 2 (GaHV-2). The disease is characterized by the presence of T cell lymphoma as well as infiltration of nerves and organs by lymphocytes. Viruses related to MDV appear to be benign and can be used as vaccine strains to prevent Marek's disease. For example, the related herpesvirus found in turkeys (HVT), causes no apparent disease in the birds, and continues to be used as a vaccine strain for prevention of Marek's disease.

<span class="mw-page-title-main">Canine influenza</span>

Canine influenza is influenza occurring in canine animals. Canine influenza is caused by varieties of influenzavirus A, such as equine influenza virus H3N8, which was discovered to cause disease in canines in 2004. Because of the lack of previous exposure to this virus, dogs have no natural immunity to it. Therefore, the disease is rapidly transmitted between individual dogs. Canine influenza may be endemic in some regional dog populations of the United States. It is a disease with a high morbidity but a low incidence of death.

Canid alphaherpesvirus 1 (CaHV-1), formerly Canine herpesvirus (CHV), is a virus of the family Herpesviridae which most importantly causes a fatal hemorrhagic disease in puppies less than two to three weeks old. It is known to exist in the United States, Canada, Australia, Japan, England and Germany. CHV was first recognized in the mid-1960s from a fatal disease in puppies.

<span class="mw-page-title-main">Equine influenza</span>

Equine influenza is the disease caused by strains of influenza A that are enzootic in horse species. Equine influenza occurs globally, previously caused by two main strains of virus: equine-1 (H7N7) and equine-2 (H3N8). The OIE now considers H7N7 strains likely to be extinct since these strains have not been isolated for over 20 years. Predominant international circulating H3N8 strains are Florida sublineage of the American lineage; clade 1 predominates in the Americas and clade 2 in Europe.. The disease has a nearly 100% infection rate in an unvaccinated horse population with no prior exposure to the virus.

H3N8 is a subtype of the species Influenza A virus that is endemic in birds, horses and dogs. It is the main cause of equine influenza and is also known as equine influenza virus. In 2011, it was reported to have been found in seals. Cats have been experimentally infected with the virus, leading to clinical signs, shedding of the virus and infection of other cats.

Bovine alphaherpesvirus 1 (BoHV-1) is a virus of the family Herpesviridae and the subfamily Alphaherpesvirinae, known to cause several diseases worldwide in cattle, including rhinotracheitis, vaginitis, balanoposthitis, abortion, conjunctivitis, and enteritis. BoHV-1 is also a contributing factor in shipping fever, also known as bovine respiratory disease (BRD). It is spread horizontally through sexual contact, artificial insemination, and aerosol transmission and it may also be transmitted vertically across the placenta. BoHV-1 can cause both clinical and subclinical infections, depending on the virulence of the strain. Although these symptoms are mainly non-life-threatening it is an economically important disease as infection may cause a drop in production and affect trade restrictions. Like other herpesviruses, BoHV-1 causes a lifelong latent infection and sporadic shedding of the virus. The sciatic nerve and trigeminal nerve are the sites of latency. A reactivated latent carrier is normally the source of infection in a herd. The clinical signs displayed are dependent on the virulence of the strain. There is a vaccine available which reduces the severity and incidence of disease. Some countries in Europe have successfully eradicated the disease by applying a strict culling policy.

Aujeszky's disease, usually called pseudorabies in the United States, is a viral disease in swine that has been endemic in most parts of the world. It is caused by Suid herpesvirus 1 (SuHV-1). Aujeszky's disease is considered to be the most economically important viral disease of swine in areas where classical swine fever has been eradicated. Other mammals, such as cattle, sheep, goats, cats, dogs, and raccoons, are also susceptible. The disease is usually fatal in these animal species.

Equid alphaherpesvirus 3, formerly Equine herpesvirus 3 (EHV-3), is a virus of the family Herpesviridae that affects horses.

Equid alphaherpesvirus 4, formerly Equine herpesvirus 4 (EHV-4) is a virus of the family Herpesviridae that cause rhinopneumonitis in horses. It is the most important viral cause of respiratory infection in foals. Like other herpes viruses, EHV-4 causes a lifelong latent infection in affected animals. These horses are usually the source for new infection for foals over two months old, weanlings, and yearlings. Symptoms include fever, loss of appetite, and discharge from the nose. Most infected animals recover in one to three weeks, but death can occur in environments with overcrowding and other stress factors. There are several vaccines available.

Equid gammaherpesvirus 2, formerly Equine herpesvirus 2 (EHV-2), is a virus of the family Herpesviridae, originally known as equine cytomegalovirus due to its slow replication in tissue culture. However, complete sequencing of the EHV-2 genome has demonstrated that it is a member of the subfamily Gammaherpesvirinae, in the genus Percavirus. It has an uncertain role in respiratory disease in horses, but EHV-2 has been isolated from cases exhibiting symptoms such as coughing, conjunctivitis, and swollen submaxillary and parotid lymph nodes.

<span class="mw-page-title-main">Feline viral rhinotracheitis</span> Infectious disease of cats

Feline viral rhinotracheitis (FVR) is an upper respiratory or pulmonary infection of cats caused by Felid alphaherpesvirus 1 (FeHV-1), of the family Herpesviridae. It is also commonly referred to as feline influenza, feline coryza, and feline pneumonia but, as these terms describe other very distinct collections of respiratory symptoms, they are misnomers for the condition. Viral respiratory diseases in cats can be serious, especially in catteries and kennels. Causing one-half of the respiratory diseases in cats, FVR is the most important of these diseases and is found worldwide. The other important cause of feline respiratory disease is feline calicivirus.

<span class="mw-page-title-main">Duck plague</span> Disease caused by Anatid alphaherpesvirus 1

Duck plague is a worldwide disease caused by Anatid alphaherpesvirus 1 (AnHV-1) of the family Herpesviridae that causes acute disease with high mortality rates in flocks of ducks, geese, and swans. It is spread both vertically and horizontally—through contaminated water and direct contact. Migratory waterfowl are a major factor in the spread of this disease as they are often asymptomatic carriers of disease. The incubation period is three to seven days. Birds as young as one week old can be infected. DEV is not zoonotic.

<span class="mw-page-title-main">Bovine malignant catarrhal fever</span> Species of virus

Bovine malignant catarrhal fever (BMCF) is a fatal lymphoproliferative disease caused by a group of ruminant gamma herpes viruses including Alcelaphine gammaherpesvirus 1 (AlHV-1) and Ovine gammaherpesvirus 2 (OvHV-2) These viruses cause unapparent infection in their reservoir hosts, but are usually fatal in cattle and other ungulates such as deer, antelope, and buffalo. In Southern Africa the disease is known as snotsiekte, from the Afrikaans.

Equine viral arteritis (EVA) is a disease of horses caused by a virus of the species Alphaarterivirus equid, an RNA virus. It is the only species in the genus Alphaarterivirus, and that is the only genus in the Equarterivirinae subfamily. The virus which causes EVA was first isolated in 1953, but the disease has afflicted equine animals worldwide for centuries. It has been more common in some breeds of horses in the United States, but there is no breed "immunity". In the UK, it is a notifiable disease. There is no known human hazard.

<span class="mw-page-title-main">Influenza</span> Infectious disease, often just "the flu"

Influenza, commonly known as "the flu", is an infectious disease caused by influenza viruses. Symptoms range from mild to severe and often include fever, runny nose, sore throat, muscle pain, headache, coughing, and fatigue. These symptoms begin from one to four days after exposure to the virus and last for about 2–8 days. Diarrhea and vomiting can occur, particularly in children. Influenza may progress to pneumonia, which can be caused by the virus or by a subsequent bacterial infection. Other complications of infection include acute respiratory distress syndrome, meningitis, encephalitis, and worsening of pre-existing health problems such as asthma and cardiovascular disease.

Bovine gammaherpesvirus 4 (BoHV-4) is a member of the Herpesviridae family. It is part of the subfamily Gammaherpesvirinae and genus Rhadinovirus. Infection is normally sub-clinical but can cause reproductive disease in cattle such as endometritis, vulvovaginitis and mastitis. Transmission is both vertical and horizontal. It can also be indirectly spread by fomites. Distribution is worldwide and the virus infects a range of ruminants, including bison, buffalo, sheep and goats.

Pacheco's disease is a highly infectious and acute bird disease caused by a species of herpesvirus, Psittacid alphaherpesvirus 1 (PsHV-1). All psittacine species are susceptible to Pacheco's disease, mainly those in zoological collections and aviaries in any geographic regions. Specifically, Pacheco's disease has a high occurrence rate in Amazon parrots, followed by African grey parrots, parrots, macaws, cockatoos and conures. Due to a very high mortality rate within these susceptible species, concerns are brought to companion bird markets and breeders.

Theiler's disease is a viral hepatitis that affects horses. It is one of the most common cause of acute hepatitis and liver failure in the horse.

References

  1. "ICTV Taxonomy". International Committee on Taxonomy of Viruses (ICTV). Retrieved 17 January 2019.
  2. Fenner, Frank J.; Gibbs, E. Paul J.; Murphy, Frederick A.; Rott, Rudolph; Studdert, Michael J.; White, David O. (1993). Veterinary Virology (2nd ed.). Academic Press, Inc. ISBN   978-0-12-253056-2.
  3. Carter, G.R.; Flores, E.F.; Wise, D.J. (2006). "Herpesviridae". A Concise Review of Veterinary Virology. Retrieved 2006-06-08.
  4. 1 2 3 4 5 6 "Equine Herpes Virus." n.d. American Association of Equine Practitioners. November 2014.
  5. 1 2 3 4 5 "Equine Herpesvirus (EHV)." December 2008. Animal and Plant Health Inspection Service. November 2014
  6. "Equine Herpes Virus type1 Status Report – Florida". Florida Department of Agriculture and Consumer Services. Archived from the original on 2007-01-06. Retrieved 2007-01-05.
  7. "Florida Department Of Agriculture And Consumer Services Continues Investigation Into Horse Virus Outbreak". Florida Department of Agriculture and Consumer Services. Archived from the original on 2010-12-01. Retrieved 2010-12-27.
  8. 1 2 D.P. Lunn, N. Davis-Poynter, M.J.B.F. Flaminio, D.W. Horohov, K. Osterrieder, N. Pusterla, H.G.G Townsned. "Equine Herpesvirus-1 Consensus Statement." May. Wiley Online Library. November 2014. http://onlinelibrary.wiley.com/doi/10.1111/j.1939-1676.2009.0304.x/full
  9. "Equine Herpesvirus (EHV) Myeloencephalopathy" (PDF). United States Department of Agriculture, Animal and Plant Health Inspection Service. Archived from the original (PDF) on August 5, 2011. Retrieved August 16, 2011.
  10. "Equine Herpesvirus (EHV-1) – Final Situation Report June 23, 2011" (PDF). United States Department of Agriculture, Animal and Plant Health Inspection Service. Archived from the original (PDF) on August 5, 2011. Retrieved August 16, 2011.
  11. 1 2 3 4 M Dunowska (2014) A review of equid herpesvirus 1 for the veterinary practitioner. Part A: Clinical presentation, diagnosis and treatment, New Zealand Veterinary Journal, 62:4, 179–188, DOI: 10.1080/00480169.2014.899946.
  12. 1 2 3 M Dunowska (2014) A review of equid herpesvirus 1 for the veterinary practitioner. Part B:pathogenesis and epidemiology, New Zealand Veterinary Journal, 62:4, 179–188, DOI: 10.1080/00480169.2014.899946